BackAgomAb Therapeutics N.V. American Depositary Shares Overview

AgomAb Therapeutics N.V. American Depositary Shares Other Liabilities

Latest other liabilities for AGMB: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

AgomAb Therapeutics N.V. American Depositary Shares Other Liabilities History

Loading

AgomAb Therapeutics N.V. American Depositary Shares vs. peers: Other Liabilities Comparison

Loading

AgomAb Therapeutics N.V. American Depositary Shares Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) FAQ

The latest other liabilities for AGMB is $0 as of June 2026. Investors often review this figure alongside AgomAb Therapeutics N.V. American Depositary Shares's historical trend and sector peers before judging valuation or financial health.

A other liabilities figure of $0 for AGMB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AGMB's other liabilities ($0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AgomAb Therapeutics N.V. American Depositary Shares's other liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.